Why should SGLT-2 inhibitors be used cautiously in late-stage diabetic nephropathy?

Sitagliptin Requires Renal Metabolism

In the later stages of diabetic nephropathy, renal function declines, affecting drug metabolism and altering pharmacokinetic curves, which more easily leads to hypoglycemia and various side effects.

Therefore, use with caution.

References